URGenT Resource Access (X01): Nonclinical & Manufacturing Support for Ultra‑Rare Gene Therapies (No Clinical Trials)
This NINDS X01 gives investigators no-cost access to URGenT CRO/CMO resources and subject-matter experts to support planning, manufacturing, and limited nonclinical development of gene- or transcript-directed therapies for ultra-rare neurological and neuromuscular diseases (clinical trials not allowed). Awardees receive a multidisciplinary project team to develop IND-enabling activities, prepa…
Source
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers